Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Identifiable Intangible Assets Carrying Value

The net carrying value of the identifiable intangible assets as of December 31, 2020 and December 31, 2019 is as follows:

			As of December 31, 2020			As of December 31, 2019
	Life		Carrying			Carrying
	(Years)		Amount			Amount
Asuragen acquisition:
Thyroid		9	$	8,519		$	8,519
RedPath acquisition:
Pancreas test		7		16,141			16,141
Barrett’s test		9		6,682			6,719
BioPharma acquisition:
Trademarks		10		1,600			1,600
Customer relationships		8		5,700			5,700
CLIA Lab		2.3	$	609		$	609
Total			$	39,251		$	39,288
Accumulated Amortization			$	(27,900	)	$	(23,439	)
Net Carrying Value			$	11,351		$	15,849

Schedule of Goodwill Carrying Value

The following table displays a roll forward of the carrying amount of goodwill from January 1, 2019 to December 31, 2020:

	Carrying
	Amount
Balance as of January 1, 2019	$	-
Goodwill acquired		8,273
Adjustments		160
Balance as of December 31, 2019		8,433
Adjustments		-
Balance as of December 31, 2020	$	8,433

Schedule of Future Estimated Amortization Expense

Amortization expense was approximately $4.5 million and $4.0 million for the years ended December 31, 2020 and 2019, respectively. Estimated amortization expense for the next five years is as follows:

2021		2022		2023		2024		2025
$	4,078	$	2,156	$	1,745	$	873	$	873